Select for export Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-023-29763-x PubMed 36774449 Copy citation Copy BibTeX Scientific Reports 2023-02-10 Grant Jones, Joshua Lipson, Erica Wang OpenAlex Published psilocybin Receptor PharmacologyObservational Study Observational Study More
Select for export Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health Abstract available at the source but not redistributed here. Read at source. Details DOI 10.9734/air/2023/v24i1931 Copy citation Copy BibTeX Advances in Research 2023-01-29 Jennings Hernandez OpenAlex Published psilocybin DepressionAnxietyPTSD Observational Study More
Select for export SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2023-01-29 Washington University School of Medicine ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionNeuroplasticityBrain Imaging Clinical Trial More
Select for export Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2023.01.077 PubMed 36707036 Copy citation Copy BibTeX Journal of Affective Disorders 2023-01-24 Nadav Liam Modlin, Tammy M. Miller, James Rucker, Namik Kirlić, Molly Lennard-Jones, Danielle Schlosser OpenAlex Published psilocybin AnxietyReceptor Pharmacology Other More
Select for export Classic psychedelics do not affect T cell and monocyte immune responses Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1042440 PubMed 36741125 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-01-19 Deborah Rudin, Alexander Areesanan, Matthias E. Liechti, Carsten Gründemann OpenAlex Published psilocin End-of-Life DistressPharmacologyReceptor Pharmacology In Vitro Study More
Select for export 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.2c00718 PubMed 36630260 Copy citation Copy BibTeX ACS Chemical Neuroscience 2023-01-10 Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas, Eden V. Barragan, Hannah N. Saeger, Hunter T. Warren OpenAlex Published psilocybin PharmacologyReceptor PharmacologySafety Other More
Select for export Are psychedelics the answer to chronic pain: A review of current literature. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/papr.13203 PubMed 36597700 Copy citation Copy BibTeX Unknown journal 2023-01-10 Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP Europe PMC Published psilocybin AddictionEnd-of-Life DistressChronic Pain Randomized Controlled Trial More
Select for export Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/cns.14054 PubMed 36627756 Copy citation Copy BibTeX CNS Neuroscience & Therapeutics 2023-01-09 Jing Wang, Min Liang, Qing Shang, Hongyan Qian, Ran An, Hua Liu OpenAlex Published psilocybinpsilocin PharmacologyMechanism of ActionReceptor Pharmacology Animal Study More
Select for export Acute psilocybin enhances cognitive flexibility in rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2023.01.09.523291 Copy citation Copy BibTeX bioRxiv 2023-01-08 Pacheco AT, Olson RJ, Garza G, Moghaddam B. bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyPharmacology Other More
Select for export Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2022.1074633 PubMed 36686713 Copy citation Copy BibTeX Frontiers in Pharmacology 2023-01-03 Kenneth Alper, Janelle Cange, Ria Sah, Deanna Schreiber-Gregory, Henry Sershen, K. Yaragudri Vinod OpenAlex Published psilocybin AddictionPharmacologyReceptor Pharmacology Animal Study More
Select for export Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.102665 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Klaus Richter Larsen, Ulrich Lindberg, Brice Ozenne, Drummond E-Wen McCulloch, Sophia Armand, M. Madsen OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.102452 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Ines Erkizia-Santamaría, Guadalupe Rivero, Igor Horrillo, J. Javier Meana, Jorge E. Ortega OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Other More
Select for export Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.102939 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Agata Machaczka, Jane Turek, Dorota Bederska-Łojewska, Bartłomiej Pochwat, Łukasz Gąsior, Bernadeta Szewczyk OpenAlex Published psilocybin DepressionReceptor Pharmacology Other More
Select for export Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.103378 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Sofia Nasini, Martina Colognesi, Sara Tidei, Sara De Martin, Marco Banzato, Andrea Mattarei OpenAlex Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Visualizing drug actions on dendrites: psilocybin and other classic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1364/brain.2023.btu2b.2 Copy citation Copy BibTeX Unknown journal 2022-12-31 Ling-Xiao Shao, Clara Liao, Ian Gregg, Pasha A. Davoudian, Neil K. Savalia, Kristina Delagarza OpenAlex Published psilocybin Receptor PharmacologyAnimal Study Animal Study More
Select for export Italian psychedelic therapies of the past century: An historical overview Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245231179687 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Adriana D’Arienzo, Giorgio Samorini OpenAlex Published psilocybin DepressionReceptor Pharmacology Other More
Select for export Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data Abstract available at the source but not redistributed here. Read at source. Details DOI 10.53053/etcr6498 Copy citation Copy BibTeX The Transmitter 2022-12-31 Peter Hess OpenAlex Published psilocybin PharmacologyReceptor PharmacologyClinical Trial Clinical Trial More
Select for export Psychedelic Drug Therapy for Mental Disorders? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4236/ojmp.2023.123010 Copy citation Copy BibTeX Open Journal of Medical Psychology 2022-12-31 John R. Rossiter OpenAlex Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvement No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.103662 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Vejmola Č., Hubený J., Koudelka V., Griškova-Bulanova I., Páleníček T. Crossref Published psilocin Receptor Pharmacology Other More
Select for export Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221140004 PubMed 36588452 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-31 Jack E. Henningfield, Judy Ashworth, David J. Heal, Sharon L. Smith OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
